NCT02003417View on ClinicalTrials.gov

Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy

CompletedOBSERVATIONAL
Enrollment

101

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

July 31, 2016

Study Completion Date

May 4, 2018

Conditions
Prostate Cancer
Trial Locations (8)

20007

Medstar Georgetown University Hospital, Washington D.C.

22908

University of Virginia, Charlottesville

27262

High Point Regional UNC Health Care, High Point

27599

University of North Carolina at Chapel Hill Cancer Hospital, Chapel Hill

27607

Rex Healthcare, Inc, Raleigh

27614

Rex Healthcare of Wakefield, Raleigh

27889

Marion L. Shepard Cancer Center, Washington

28401

Coastal Carolina Radiation Oncology, Wilmington

All Listed Sponsors
collaborator

Radiation Therapy Oncology Group

NETWORK

lead

UNC Lineberger Comprehensive Cancer Center

OTHER

NCT02003417 - Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy | Biotech Hunter | Biotech Hunter